GoAI
Get started
MiniMed Group, Inc. Common Stock logo

MiniMed Group, Inc. Common Stock

MMED

NASDAQHealthcareMedical - Equipment & Services

Open in GoAI

Previous close

$20.45

+$0.27 · +1.34%

Aug 21, 4:00 PM ET

MMED company overview

Historical prices · Market data may be delayed.

Company profile

Company website

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Industry
Medical - Equipment & Services
Sector
Healthcare
Headquarters
US
CEO
Que Thanh Dallara
Listed since
Mar 5, 2026
Employees
8,000

Market position

Day range

Current $20.45

52-week range

Current $20.45

Open
$20.34
Previous close
$20.18
Volume
1.12M
1.1× average
Average volume
1.02M
Average daily volume
Market cap
5.74B USD
Beta
-3.68
Market reference 1
50-day average
$16.868
+21.24% above average
200-day average
$15.1104
+35.34% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
3.23B USD
P/E (TTM)
-18.59×
P/B (TTM)
1.52×
P/S (TTM)
2.44×
EV / EBITDA
66×
Earnings yield
-9.77%
Free cash flow yield
-12.40%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
52.91%
Operating margin
-9.15%
Net margin
-21.74%
Return on equity
-9.17%
Return on assets
-7.15%
Return on invested capital
1.20%

Financial health

Debt / equity
0.04×
Current ratio
1.92×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends65%38%10%-18%Gross margin, FY2022: 58.26%Gross margin, FY2023: 58.16%Gross margin, FY2024: 56.17%Gross margin, FY2025: 54.16%Operating margin, FY2022: -3.07%Operating margin, FY2023: -2.79%Operating margin, FY2024: -7.44%Operating margin, FY2025: 1.58%Net margin, FY2022: -4.28%Net margin, FY2023: -4.54%Net margin, FY2024: -9.21%Net margin, FY2025: -10.67%FY2022FY2023FY2024FY2025
Gross margin FY2022 58.26%. Gross margin FY2023 58.16%. Gross margin FY2024 56.17%. Gross margin FY2025 54.16%. Operating margin FY2022 -3.07%. Operating margin FY2023 -2.79%. Operating margin FY2024 -7.44%. Operating margin FY2025 1.58%. Net margin FY2022 -4.28%. Net margin FY2023 -4.54%. Net margin FY2024 -9.21%. Net margin FY2025 -10.67%.

Income trends

Revenue

3.1B USD+14.25%

Operating income

49M USD+251M USD

Net income

−331M USD-32.40%
Income trends across reported periods3.45B USD2.07B USD698.9M USD−674.3M USDRevenue, FY2022: 2.25B USDRevenue, FY2023: 2.47B USDRevenue, FY2024: 2.72B USDRevenue, FY2025: 3.1B USDOperating income, FY2022: −69M USDOperating income, FY2023: −69M USDOperating income, FY2024: −202M USDOperating income, FY2025: 49M USDNet income, FY2022: −96M USDNet income, FY2023: −112M USDNet income, FY2024: −250M USDNet income, FY2025: −331M USDFY2022FY2023FY2024FY2025
Revenue FY2022 2.25B USD. Revenue FY2023 2.47B USD. Revenue FY2024 2.72B USD. Revenue FY2025 3.1B USD. Operating income FY2022 −69M USD. Operating income FY2023 −69M USD. Operating income FY2024 −202M USD. Operating income FY2025 49M USD. Net income FY2022 −96M USD. Net income FY2023 −112M USD. Net income FY2024 −250M USD. Net income FY2025 −331M USD.
Metric (USD)FY2025FY2024FY2023FY2022
Revenue3.1B USD2.72B USD2.47B USD2.25B USD
Cost of goods sold1.42B USD1.19B USD1.03B USD937M USD
Gross profit1.68B USD1.53B USD1.44B USD1.31B USD
Research and development448M USD438M USD437M USD429M USD
Selling, general, and administrative1.18B USD1.13B USD1.06B USD960M USD
Operating expenses1.63B USD1.73B USD1.51B USD1.38B USD
Depreciation and amortization—143M USD129M USD115M USD
Operating income49M USD−202M USD−69M USD−69M USD
Net income−331M USD−250M USD−112M USD−96M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
0%
0 beats, 2 misses, 0 met estimates
Average EPS surprise
-275.08%
2 comparable reports
Latest EPS result
-0.68
Estimate -0.15 · Miss by 356.16%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.24-0.09-0.42-0.75Q2 '26MissQ2 '26MissQ3 '26Estimate
Q2 2026, reported Apr 17, 2026: actual -0.16, estimate 0.17, surprise -194.01%, Miss. Q2 2026, reported Jun 3, 2026: actual -0.68, estimate -0.149, surprise -356.16%, Miss. Q3 2026, reported Sep 1, 2026: actual —, estimate 0.09, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates870.48M832.32M794.16M756MQ2 '26BeatQ2 '26BeatQ3 '26Estimate
Q2 2026, reported Apr 17, 2026: actual 790M USD, estimate 789.48M USD, surprise +0.07%, Beat. Q2 2026, reported Jun 3, 2026: actual 837M USD, estimate 828.61M USD, surprise +1.01%, Beat. Q3 2026, reported Sep 1, 2026: actual —, estimate 826.8M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

2 institutions
Wells FargomaintainOverweight
B of A SecuritiesmaintainBuy

MMED news

zacks.com

MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor

MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discreet app control with automated insulin delivery.

Read source
prnewswire.com

MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor

MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026…

Read source
fool.com

This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run

Medtronic could finally be on the cusp of a long-awaited turnaround.

Read source
zacks.com

MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access

MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.

Read source
seekingalpha.com

MiniMed: Next-Generation Diabetes Platform Supports A Buy Rating

MiniMed Group, a Medtronic spin-off, is rated a buy with an FY 2027 price target of $19, implying 15% upside. MMED's double-digit revenue growth is driven by strong international adoption, expanding CGM attach rates, and…

Read source
prnewswire.com

MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries

NORTHRIDGE, Calif., July 22, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Medicare and Medicare Advantage beneficiaries now have access to the MiniMed Flex™…

Read source

MMED peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding MMED

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
14.95M
Weight
0.02%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
First Trust US Equity Opportunities ETF logoFirst Trust US Equity Opportunities ETFFPX
Market value
7.4M
Weight
0.49%
AUM
1.51B USD
Expense ratio
0.57%
Price / 1D
$183.88+0.42%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
5.85M
Weight
0.01%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
5.38M
Weight
0.04%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%
Ballast Small/Mid Cap ETF logoBallast Small/Mid Cap ETFMGMT
Market value
3.4M
Weight
1.94%
AUM
150.32M USD
Expense ratio
1.10%
Price / 1D
$51.655+0.45%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
2.92M
Weight
0.02%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
2.68M
Weight
0.01%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
Fidelity Nasdaq Composite Index ETF logoFidelity Nasdaq Composite Index ETFONEQ
Market value
1.55M
Weight
0.01%
AUM
10.35B USD
Expense ratio
0.21%
Price / 1D
$103.14+0.41%

Continue in GoAI

Research MMED

research.disclaimer